Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. https://doi.org/10.3322/caac.21834.
Ahmad AS, Offman J, Delon C, North BV, Shelton J, Sasieni PD. Years of life lost due to cancer in the United Kingdom from 1988 to 2017. Br J Cancer. 2023;129:1558–68. https://doi.org/10.1038/s41416-023-02422-8
Google Scholar
Chari ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol. 2007;34:284–94. https://doi.org/10.1053/j.seminoncol.2007.05.005
Google Scholar
Zhang L, Sanagapalli S, Stoita A. Challenges in diagnosis of pancreatic cancer. World J Gastroenterol. 2018;24:2047–60. https://doi.org/10.3748/wjg.v24.i19.2047
Google Scholar
Wood DE, Kazerooni EA, Aberle D, Berman A, Brown LM, Eapen GA, et al. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. J Natl Compr Cancer Netw. 2022;20:754–64. https://doi.org/10.6004/jnccn.2022.0036
Google Scholar
Corner J, Hopkinson J, Roffe L. Experience of health changes and reasons for delay in seeking care: a UK study of the months prior to the diagnosis of lung cancer. Soc Sci Med. 2024;62:1381–91. https://doi.org/10.1016/j.socscimed.2005.08.012
Google Scholar
Sun VC-Y, Sarna L. Symptom management in hepatocellular carcinoma. Clin J Oncol Nurs. 2008;12:759–66. https://doi.org/10.1188/08.cjon.759-766
Google Scholar
Waleleng BJ, Adiwinata R, Wenas NT, Haroen H, Rotty L, Gosal F, et al. Screening of pancreatic cancer: target population, optimal timing and how? Ann Med Surg. 2022;84. https://doi.org/10.1016/j.amsu.2022.104814.
Liam C-K, Liam Y-S, Poh M-E, Wong C-K. Accuracy of lung cancer staging in the multidisciplinary team setting. Transl Lung Cancer Res. 2020;9:1654–66. https://doi.org/10.21037/tlcr.2019.11.28
Google Scholar
Huber RM, Cavic M, Kerpel-Fronius A, Viola L, Field J, Jiang L, et al. Lung cancer screening considerations during respiratory infection outbreaks, epidemics or pandemics: an international association for the study of lung cancer early detection and screening committee report. J Thorac Oncol. 2024;17:228–38. https://doi.org/10.1016/j.jtho.2021.11.008
Google Scholar
Choi J-Y, Lee J-M, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: Part II. extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology. 2014;273:30–50. https://doi.org/10.1148/radiol.14132362
Google Scholar
Di Tommaso L, Spadaccini M, Donadon M, Personeni N, Elamin A, Aghemo A, et al. Role of liver biopsy in hepatocellular carcinoma. World J Gastroenterol. 2019;25:6041–52. https://doi.org/10.3748/wjg.v25.i40.6041
Google Scholar
Walter FM, Penfold C, Joannides A, Saji S, Johnson M, Watts C, et al. Missed opportunities for diagnosing brain tumours in primary care: a qualitative study of patient experiences. Br J Gen Pract. 2024;69:e224–35. https://doi.org/10.3399/bjgp19x701861
Google Scholar
Jozsa F, Gaier C, Ma Y, Kitchen N, McEvoy A, Miserocchi A, et al. Safety and efficacy of brain biopsy: results from a single institution retrospective cohort study. Brain Spine. 2023;3:101763. https://doi.org/10.1016/j.bas.2023.101763
Google Scholar
Ambros V. Control of developmental timing in Caenorhabditis elegans. Curr Opin Genet Dev. 2000;10:428–33. https://doi.org/10.1016/s0959-437x(00)00108-8
Google Scholar
Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403:901–6. https://doi.org/10.1038/35002607
Google Scholar
Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005;353:1793–801. https://doi.org/10.1056/nejmoa050995
Google Scholar
Rodriguez A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004;14:1902–10. https://doi.org/10.1101/gr.2722704
Google Scholar
Lee Y, Kim M, Han J, Yeom K-H, Lee S, Baek SH, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2024;23:4051–60. https://doi.org/10.1038/sj.emboj.7600385
Google Scholar
Cai X. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA. 2004;10:1957–66. https://doi.org/10.1261/rna.7135204
Google Scholar
Yi R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003;17:3011–6. https://doi.org/10.1101/gad.1158803
Google Scholar
Pratt AJ, MacRae IJ. The RNA-induced silencing complex: a versatile gene-silencing machine. J Biol Chem. 2009;284:17897–901. https://doi.org/10.1074/jbc.r900012200
Google Scholar
Medley JC, Panzade G, Zinovyeva AY. microRNA strand selection: Unwinding the rules. WIREs RNA. 2020. https://doi.org/10.1002/wrna.1627.
Bendich A, Wilczok T, Borenfreund E. Circulating DNA as a possible factor in oncogenesis. Science. 1965;148:374–6. https://doi.org/10.1126/science.148.3668.374
Google Scholar
Mandel P, Metais P. Nuclear acids in human blood plasma. C R Seances Soc Biol Fil. 1948;142:241–3.
Google Scholar
Hasselmann DO, Rappl G, Rössler M, Ugurel S, Tilgen W, Reinhold U. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma. Oncol Rep. 2001. https://doi.org/10.3892/or.8.1.115.
Stroun M, Anker P, Maurice P, Gahan PB. Circulating nucleic acids in higher organisms. Int Rev Cytol. 1977;51:1–48. https://doi.org/10.1016/s0074-7696(08)60225-9
Google Scholar
Kamm RC, Smith AG. Ribonuclease activity in human plasma. Clin Biochem. 1972;5:198–200. https://doi.org/10.1016/S0009-9120(72)80033-X
Google Scholar
Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA. 2007;13:1668–74. https://doi.org/10.1261/rna.642907
Google Scholar
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997–1006. https://doi.org/10.1038/cr.2008.282
Google Scholar
Hu G, Drescher K, Chen X. Exosomal miRNAs: biological properties and therapeutic potential. Front Genet. 2012;3. https://doi.org/10.3389/fgene.2012.00056.
Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci. 2012;37:460–5. https://doi.org/10.1016/j.tibs.2012.08.003
Google Scholar
Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654–9. https://doi.org/10.1038/ncb1596
Google Scholar
Li L, Zhu D, Huang L, Zhang J, Bian Z, Chen X, et al. Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PLoS ONE. 2012;7:e46957. https://doi.org/10.1371/journal.pone.0046957
Google Scholar
Elkayam E, Kuhn C-D, Tocilj A, Haase AD, Greene E, Hannon GJ, et al. The structure of human argonaute-2 in complex with miR-20a. Cell. 2012;150:100–10. https://doi.org/10.1016/j.cell.2012.05.017
Google Scholar
Hüttenhofer A, Mayer G. Circulating miRNAs as biomarkers of kidney disease. Clin Kidney J. 2016:sfw075. https://doi.org/10.1093/ckj/sfw075.
Chevillet JR, Kang Q, Ruf IK, Briggs HA, Vojtech LN, Hughes SM, et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci USA. 2014;111:14888–93. https://doi.org/10.1073/pnas.1408301111
Google Scholar
Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141:672–5. https://doi.org/10.1111/j.1365-2141.2008.07077.x
Google Scholar
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8. https://doi.org/10.1038/nature03702
Google Scholar
Shi W, Wartmann T, Accuffi S, Al-Madhi S, Perrakis A, Kahlert C, et al. Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer. Br J Cancer. 2024;130:125–34. https://doi.org/10.1038/s41416-023-02488-4
Google Scholar
Ciello Adel, Franchi P, Contegiacomo A, Cicchetti G, Bonomo L, Larici AR. Missed lung cancer: when, where, and why? Diagn Interv Radiol. 2017;23:118–26. https://doi.org/10.5152/dir.2016.16187
Google Scholar
Dong X, Chang M, Song X, Ding S, Xie L, Song X. Plasma miR‐1247‐5p, miR‐301b‐3p and miR‐105‐5p as potential biomarkers for early diagnosis of non‐small cell lung cancer. Thorac Cancer. 2020;12:539–48. https://doi.org/10.1111/1759-7714.13800
Google Scholar
Liu H, Ma X, Niu N, Zhao J, Lu C, Yang F, et al. MIR-301b-3p promotes lung adenocarcinoma cell proliferation, migration and invasion by targeting DLC1. Technol Cancer Res Treat. 2021;20:153303382199003. https://doi.org/10.1177/1533033821990036
Google Scholar
Li P, Xing W, Xu J, Yuan D, Liang G, Liu B, et al. microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer. Stem Cell Res Ther. 2019;10. https://doi.org/10.1186/s13287-019-1235-8.
Arab A, Karimipoor M, Irani S, Kiani A, Zeinali S, Tafsiri E, et al. Potential circulating miRNA signature for early detection of NSCLC. Cancer Genet. 2017;216217:150–8. https://doi.org/10.1016/j.cancergen.2017.07.006
Google Scholar
Amr KS, Elmawgoud Atia HA, Elazeem Elbnhawy RA, Ezzat WM. Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma. Genes Dis. 2017;4:215–21. https://doi.org/10.1016/j.gendis.2017.10.003
Google Scholar
Lu M, Kong X, Wang H, Huang G, Ye C, He Z. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Oncotarget. 2017;8:8775–84. https://doi.org/10.18632/oncotarget.14452
Google Scholar
Shehab-Eldeen S, Nada A, Abou-Elela D, El-Naidany S, Arafat E, Omar T. Diagnostic performance of microRNA-122 and microRNA-224 in Hepatitis C virus-induced hepatocellular carcinoma (HCC). Asian Pac J Cancer Prev. 2019;20:2515–22. https://doi.org/10.31557/apjcp.2019.20.8.2515
Google Scholar
Wei X, Liu H, Li X, Liu X. Overexpression of MiR122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4. Ann Hepatol. 2019;18:869–78. https://doi.org/10.1016/j.aohep.2019.07.005
Google Scholar
Nomair AM, Issa NM, Madkour MA, Shamseya MM. The clinical significance of serum miRNA-224 expression in hepatocellular carcinoma. Clin Exp Hepatol. 2020;6:20–7. https://doi.org/10.5114/ceh.2020.93052
Google Scholar
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30. https://doi.org/10.3322/caac.21590
Google Scholar
Kopkova A, Sana J, Fadrus P, Machackova T, Vecera M, Vybihal V, et al. MicroRNA isolation and quantification in cerebrospinal fluid: a comparative methodical study. PLoS ONE. 2018;13:e0208580. https://doi.org/10.1371/journal.pone.0208580
Google Scholar
Teplyuk NM, Mollenhauer B, Gabriely G, Giese A, Kim E, Smolsky M, et al. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro Oncol. 2012;14:689–700. https://doi.org/10.1093/neuonc/nos074
Google Scholar
Akers JC, Hua W, Li H, Ramakrishnan V, Yang Z, Quan K, et al. A cerebrospinal fluid microRNA signature as biomarker for glioblastoma. Oncotarget. 2017;8:68769–79. https://doi.org/10.18632/oncotarget.18332
Google Scholar
Shalaby T, Fiaschetti G, Baulande S, Gerber N, Baumgartner M, Grotzer M. Detection and quantification of extracellular microRNAs in medulloblastoma. J Cancer Metastasis Treat. 2015;1:67. https://doi.org/10.4103/2394-4722.157068
Google Scholar
Kopkova A, Sana J, Machackova T, Vecera M, Radova L, Trachtova K, et al. Cerebrospinal fluid microRNA signatures as diagnostic biomarkers in brain tumors. Cancers. 2019;11:1546. https://doi.org/10.3390/cancers11101546
Google Scholar
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Realtime quantification of microRNAs by stem–loop RT–PCR. Nucleic Acids Res. 2005;33:e179. https://doi.org/10.1093/nar/gni178
Google Scholar
Mestdagh P, Hartmann N, Baeriswyl L, Andreasen D, Bernard N, Chen C, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods. 2014;11:809–15. https://doi.org/10.1038/nmeth.3014
Google Scholar
Foye C, Yan IK, David W, Shukla N, Habboush Y, Chase L, et al. Comparison of miRNA quantitation by Nanostring in serum and plasma samples. PLoS ONE. 2017;12:e0189165. https://doi.org/10.1371/journal.pone.0189165
Google Scholar
Armstrong DA, Green BB, Seigne JD, Schned AR, Marsit CJ. MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer. Mol Cancer. 2015;14. https://doi.org/10.1186/s12943-015-0466-2.
Buschmann D, Haberberger A, Kirchner B, Spornraft M, Riedmaier I, Schelling G, et al. Toward reliable biomarker signatures in the age of liquid biopsies – how to standardize the small RNA-Seq workflow. Nucleic Acids Res. 2016;44:5995–6018. https://doi.org/10.1093/nar/gkw545
Google Scholar
Fromm B, Høye E, Domanska D, Zhong X, Aparicio-Puerta E, Ovchinnikov VV, et al. MirGeneDB 2.1: toward a complete sampling of all major animal phyla. Nucleic Acids Res. 2021;50:D204–10. https://doi.org/10.1093/nar/gkab1101
Google Scholar
Fromm B, Zhong X, Tarbier M, Friedlander MR, Hackenberg M. The limits of human microRNA annotation have been met. RNA. 2022;28:rna.079098.122. https://doi.org/10.1261/rna.079098.122
Google Scholar
Khamina K, Diendorfer AB, Skalicky S, Weigl M, Pultar M, Krammer TL, et al. A microRNA next-generation-sequencing discovery assay (miND) for genome-scale analysis and absolute quantitation of circulating microrna biomarkers. Int J Mol Sci. 2022;23:1226. https://doi.org/10.3390/ijms23031226
Google Scholar
Cai S, Pataillot-Meakin T, Shibakawa A, Ren R, Bevan CL, Ladame S, et al. Single-molecule amplification-free multiplexed detection of circulating microRNA cancer biomarkers from serum. Nat Commun. 2021;12. https://doi.org/10.1038/s41467-021-23497-y
Ekiz Kanik F, Celebi I, Sevenler D, Tanriverdi K, Lortlar Ünlü N, Freedman JE, et al. Attomolar sensitivity microRNA detection using real-time digital microarrays. Sci Rep. 2022;12. https://doi.org/10.1038/s41598-022-19912-z
Sathipati SY, Tsai M, Shukla SK, Ho S-Y. Artificial intelligence-driven pan-cancer analysis reveals miRNA signatures for cancer stage prediction. Hum Genet Genomics Adv. 2023;4:100190. https://doi.org/10.1016/j.xhgg.2023.100190
Google Scholar
Chi H, Chen H, Wang R, Zhang J, Jiang L, Zhang S, et al. Proposing new early detection indicators for pancreatic cancer: Combining machine learning and neural networks for serum miRNA-based diagnostic model. Front Oncol. 2023;13. https://doi.org/10.3389/fonc.2023.1244578
Levin Y, Talsania K, Tran B, Shetty J, Zhao Y, Mehta M. Optimization for sequencing and analysis of degraded FFPE-RNA Samples. J Vis Exp. 2020. https://doi.org/10.3791/61060
Ottestad AL, Emdal EF, Grønberg BH, Halvorsen TO, Dai HY. Fragmentation assessment of FFPE DNA helps in evaluating NGS library complexity and interpretation of NGS results. Exp Mol Pathol. 2022;126:104771. https://doi.org/10.1016/j.yexmp.2022.104771
Google Scholar
Joshi P, Dhar R. EpICC: a Bayesian neural network model with uncertainty correction for a more accurate classification of cancer. Sci Rep. 2022;12. https://doi.org/10.1038/s41598-022-18874-6
Weber JA, Baxter DH, Zhang S, Huang DY, How Huang K, Jen Lee M, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56:1733–41. https://doi.org/10.1373/clinchem.2010.147405
Google Scholar
Glinge C, Clauss S, Boddum K, Jabbari R, Jabbari J, Risgaard B, et al. Stability of circulating blood-based microRNAs – pre-analytic methodological considerations. PLoS ONE. 2017;12:e0167969. https://doi.org/10.1371/journal.pone.0167969
Google Scholar
Kupec T, Bleilevens A, Iborra S, Najjari L, Wittenborn J, Maurer J, et al. Stability of circulating microRNAs in serum. PLoS ONE. 2022;17:e0268958. https://doi.org/10.1371/journal.pone.0268958
Google Scholar
Matias-Garcia PR, Wilson R, Mussack V, Reischl E, Waldenberger M, Gieger C, et al. Impact of long-term storage and freeze-thawing on eight circulating microRNAs in plasma samples. PLoS ONE. 2020;15:e0227648. https://doi.org/10.1371/journal.pone.0227648
Google Scholar
Chan S-F, He C, Kai-Rui KG, Zou R. Preanalytic methodological considerations and sample quality control of circulating miRNAs. J Mol Diagn. 2023;25:438–53. https://doi.org/10.1016/j.jmoldx.2023.03.005
Google Scholar
MacLellan SA, MacAulay C, Lam S, Garnis C. Pre-profiling factors influencing serum microRNA levels. BMC Clin Pathol. 2014;14. https://doi.org/10.1186/1472-6890-14-27.
Mitchell AJ, Gray WD, Hayek SS, Ko Y-A, Thomas S, Rooney K, et al. Platelets confound the measurement of extracellular miRNA in archived plasma. Sci Rep. 2016;6:32651. https://doi.org/10.1038/srep32651
Google Scholar
Simon LM, Edelstein LC, Nagalla S, Woodley AB, Chen ES, Kong X, et al. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood. 2014;123:e37–45. https://doi.org/10.1182/blood-2013-12-544692
Google Scholar
Becker KC, Kwee LC, Neely ML, Grass E, Jakubowski JA, Fox KAA, et al. Circulating microRNA profiling in Non-ST elevated coronary artery syndrome highlights genomic associations with serial platelet reactivity measurements. Sci Rep. 2020;10:6169. https://doi.org/10.1038/s41598-020-63263-6
Google Scholar
Dluzen DF, Noren Hooten N, De S, Wood WH, Zhang Y, Becker KG, et al. Extracellular RNA profiles with human age. Aging Cell. 2018;17:e12785. https://doi.org/10.1111/acel.12785
Google Scholar
Meder B, Backes C, Haas J, Leidinger P, Stähler C, Großmann T, et al. Influence of the confounding factors age and sex on microRNA profiles from peripheral blood. Clin Chem. 2014;60:1200–8. https://doi.org/10.1373/clinchem.2014.224238
Google Scholar
Lischka J, Schanzer A, Hojreh A, Ba-Ssalamah A, de Gier C, Valent I, et al. Circulating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patients. Int J Obes. 2021;45:1763–72. https://doi.org/10.1038/s41366-021-00842-1
Google Scholar
Kasiappan R, Rajarajan D. Role of MicroRNA regulation in obesity-associated breast cancer: nutritional perspectives. Adv Nutr Int Rev J. 2017;8:868–88. https://doi.org/10.3945/an.117.015800
Google Scholar
Liu R, Chen X, Du Y, Yao W, Shen L, Wang C, et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem. 2012;58:610–8. https://doi.org/10.1373/clinchem.2011.172767
Google Scholar
Nakamura K, Zhu Z, Roy S, Jun E, Han H, Munoz RM, et al. An exosome-based transcriptomic signature for noninvasive, early detection of patients with pancreatic ductal adenocarcinoma: a multicenter cohort study. Gastroenterology. 2022;163:1252–66.e2.
Google Scholar
Makler A, Asghar W. Exosomal miRNA biomarker panel for pancreatic ductal adenocarcinoma detection in patient plasma: a pilot study. Int J Mol Sci. 2023;24. https://doi.org/10.3390/ijms24065081.
Hennessey PT, Sanford T, Choudhary A, Mydlarz WW, Brown D, Adai AT, et al. Serum microrna biomarkers for detection of non-small cell lung cancer. PLoS ONE. 2012;7. https://doi.org/10.1371/journal.pone.0032307
Sanfiorenzo C, Ilie MI, Belaid A, Barlési F, Mouroux J, Marquette CH, et al. Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS ONE. 2013;8. https://doi.org/10.1371/journal.pone.0054596.
Liao J, Shen J, Leng Q, Qin M, Zhan M, Jiang F. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC). Thorac Cancer. 2020;11:762–8. https://doi.org/10.1111/1759-7714.13337
Google Scholar
Fang Y, Yan D, Wang L, Zhang J, He Q. Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma. J Clin Lab Anal. 2022;36. https://doi.org/10.1002/jcla.24541
Tan Y, Ge G, Pan T, Wen D, Chen L, Yu X, et al. A serum microrna panel as potential biomarkers for hepatocellular carcinoma related with hepatitis b virus. PLoS ONE. 2014;9:e66577. https://doi.org/10.1371/journal.pone.0107986
Google Scholar
Cho HJ, Baek GO, Seo CW, Ahn HR, Sung S, Son JA, et al. Exosomal microRNA-4661-5p–based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma. Cancer Med. 2020;9:5459–72. https://doi.org/10.1002/cam4.3230
Google Scholar
Zhang Y, Li T, Qiu Y, Zhang T, Guo P, Ma X, et al. Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma. Medicine. 2017;96. https://doi.org/10.1097/MD.0000000000005642
Baraniskin A, Kuhnhenn J, Schlegel U, Maghnouj A, Zöllner H, Schmiegel W, et al. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma. Neuro Oncol. 2012;14:29–33. https://doi.org/10.1093/neuonc/nor169
Google Scholar
Ivo D’urso P, Fernando D’urso O, Damiano Gianfreda C, Mezzolla V, Storelli C, Marsigliante S. miR-15b and miR-21 as circulating biomarkers for diagnosis of glioma. Curr Genomics. 2015;16:304–11.
Google Scholar
Lai NS, Wu DG, Fang XG, Lin YC, Chen SS, Li ZB, et al. Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma. Br J Cancer. 2015;112:1241–6. https://doi.org/10.1038/bjc.2015.91
Google Scholar
